Detect C3d-binding donor-specific anti-HLA antibodies (DSAs) for better risk stratification of patients.
The LIFECODES C3d Assay provides a measure of the binding and processing of complement to one of its end products – C3d. When combined with our LIFECODES LSA Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies.
- Identifies complement binding antibodies
- Streamlines work flow with MATCH IT!® Antibody software
- Utilizes highly sensitive Luminex® xMAP® technology
Product offerings may differ by region, please check with your local Immucor representative for regulatory status in your area.
Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia
Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network
Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory
Webinars & Workshops
Effect of HLA class I signal peptide variation on HLA-E expression and natural killer cell function
October 14th 2022
ASHI Annual Meeting 2022
October 24th 2022
Immunohematology Wet Workshop – Arkansas, USA
November 2nd 2022